Stay updated on Rituximab in Eosinophilic Granulomatosis Clinical Trial

Sign up to get notified when there's something new on the Rituximab in Eosinophilic Granulomatosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rituximab in Eosinophilic Granulomatosis Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the funding-lapse notice and the previous Revision: v3.4.1 text.
    Difference
    0.4%
    Check dated 2026-02-11T01:36:08.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and open-status update, and updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-03T22:28:55.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Glossary, Related Info, sponsor affiliations (Assistance Publique - Hôpitaux de Paris), helpful links, and expanded drug/MeSH term listings have been added, along with IPD sharing plan details. The 'No FEAR Act data' entry has been removed.
    Difference
    61%
    Check dated 2026-01-27T19:54:34.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Added a Locations section for Paris (Paris, France, 75014) with site URC-CIC Paris Descartes Necker Cochin, and a new Study Results note about voluntary publications; removed the previous PubMed-derived Paris location and older update entries.
    Difference
    0.6%
    Check dated 2026-01-20T14:31:56.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Footer shows a new Revision: v3.3.3 and removes HHS Vulnerability Disclosure and Revision: v3.3.2. These are minor maintenance changes that do not alter study details or eligibility information.
    Difference
    0.1%
    Check dated 2025-12-22T22:55:08.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.3.2, replacing the prior Revision: v3.3.1. This change is limited to a version label in the site footer and does not affect the study details, eligibility criteria, outcomes, or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T11:51:36.000Z thumbnail image

Stay in the know with updates to Rituximab in Eosinophilic Granulomatosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rituximab in Eosinophilic Granulomatosis Clinical Trial page.